J. Abraham – författare
Visar alla böcker från författaren J. Abraham. Handla med fri frakt och snabb leverans.
5 produkter
Unhealthy Pharmaceutical Regulation
Innovation, Politics and Promissory Science
Av C. Davis, J. Abraham
Inbunden, 2013
1006 kr
Lägg i varukorg
This is the first book to examine how effectively American and supranational EU governments have regulated innovative pharmaceuticals during the last 30 years regarding public health. It explains why pharmaceutical regulation has been misdirected by commercial interests and misconceived ideologies.
Regulation of the Pharmaceutical Industry
Av H. Lawton Smith, J. Abraham
E-bok, 2003
1596 kr
Lägg i varukorg
How are pharmaceutical technologies developed and controlled in our societies? To what extent should the availability of these technologies be determined by scientific experts, a democratic state, the interests of final users, or ethical principles? This unique collection brings together the work …
Regulation of the Pharmaceutical Industry
Av J. Abraham, H. Lawton Smith
Inbunden, 2003
1128 kr
Lägg i varukorg
How are pharmaceutical technologies developed and controlled in our societies? To what extent should the availability of these technologies be determined by scientific experts, a democratic state, the interests of final users, or ethical principles? This unique collection brings together the work …
Unhealthy Pharmaceutical Regulation
Innovation, Politics and Promissory Science
Av J. Abraham, C. Davis
E-bok, 2013
1516 kr
Lägg i varukorg
This is the first book to examine how effectively American and supranational EU governments have regulated innovative pharmaceuticals during the last 30 years regarding public health. It explains why pharmaceutical regulation has been misdirected by commercial interests and misconceived ideologies.
Unhealthy Pharmaceutical Regulation
Innovation, Politics and Promissory Science
Av C. Davis, J. Abraham
Häftad, 2013
1128 kr
Lägg i varukorg
This is the first book to examine how effectively American and supranational EU governments have regulated innovative pharmaceuticals during the last 30 years regarding public health. It explains why pharmaceutical regulation has been misdirected by commercial interests and misconceived ideologies.
